STAA Q3 2024 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q3 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$89M+10.3% YoY

Gross Profit

$68M77.3% margin

Operating Income

$6M6.4% margin

Net Income

$10M11.3% margin

EPS (Diluted)

$0.20

QoQ Revenue Growth

-10.5%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$15M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$538M

Total Liabilities

$109M

Stockholders' Equity

$428M

Cash & Equivalents

$164M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$80M	+10.3%
Gross Profit	$68M	$64M	+7.6%
Operating Income	$6M	$6M	-9.7%
Net Income	$10M	$5M	+107.2%

Revenue Segments

Implantable Collamer Lenses

$89M100%